恩帕格利弗洛辛对全身血动力学功能的影响:三项随机对照,安慰剂对照试验
Steffen F Nielsen1,2, Camilla L Duus1,2, Niels Henrik Buus2,3
1University Clinic in Nephrology and Hypertension, Gødstrup Hospital, Herning.
Journal of hypertension
|March 29, 2025
概括
在患有2型糖尿病和/或慢性病的患者中,empagliflozin降低了动脉硬度和血压. 该药物降低了红细胞的敏感性,可能改善内皮细胞糖功能.
科学领域:
- 心血管药理学心血管药理学
- 腎臟病學 (nephrology) 是一種醫學專業.
- 内分泌学 在内分泌学.
背景情况:
- 已知SGLT2抑制剂通过各种机制降低血压,包括血管效应.
- 了解这些机制对于优化2型糖尿病 (DM2) 和慢性病 (CKD) 患者的治疗至关重要.
研究的目的:
- 调查empagliflozin在患有或没有CKD的DM2患者以及非糖尿病CKD患者的全身血动力学影响.
- 探索empagliflozin对动脉硬,血压和内皮功能标志物的影响.
主要方法:
- 三个随机,双盲,安慰剂控制的交叉试验在患有DM2 (保留功能或CKD) 和非糖尿病CKD的患者中进行.
- 参与者接受了empagliflozin或安慰剂4周,随后是2周的洗期.
- 测量了全身血液动力学,包括门诊血压 (ABP),脉冲波速度 (PWV),增强指数 (AIx@75),氧化标志物,红细胞敏感性 (ESS) 和内皮糖体功能.
主要成果:
- 在综合研究人群中,empagliflozin显著降低了PWV,AIx@75,以及手臂和中央ABP.
- 在PWV和AIx@75的变化与缩手臂ABP的减少相关.
- 没有观察到氧化标志物的增加,但empagliflozin降低了ESS,与血液度的增加相关.
结论:
- 恩帕格利弗洛辛有效地降低了动脉硬度和血压,部分是通过减少的手臂ABP调解的.
- 在没有增加氧化的情况下,观察到的ESS下降表明内皮糖核功能可能有所改善.
- 这些发现有助于了解糖尿病和非糖尿病病患者SGLT2抑制的血管机制.
相关概念视频
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
01:26Oral Hypoglycemic Agents: Biguanides and Glitazones
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood glucose levels...
01:06Oral Hypoglycemic Agents: Glinides
Repaglinide (Prandin) and Nateglinide (Starlix), known as glinides, are oral insulin secretagogues that stimulate insulin release from pancreatic β cells by closing the ATP-sensitive potassium channels (KATP channel). Repaglinide controls insulin release from pancreatic β cells by managing potassium efflux. It shares two binding sites with sulfonylureas and also has a unique site, indicating overlapping mechanisms of action. With a rapid onset and a 4-7 hour duration, it effectively manages...
01:23Dipeptidyl Peptidase 4 Inhibitors
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a significant...
01:30Heart Failure V: Medical Management
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
01:30Hypertension III: Clinical Manifestations and Diagnostic Studies
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...